Arch Pharmalabs signs MoU with France-based Texcell SA

NEW DELHI: Drug firm Arch Pharmalabs on Thursday said it has signed a memorandum of understanding with France-based Texcell SA for providing immunology and viral safety services in India.

As par the MoU, Arch Pharma would provide the safety norms and other facilities needed in the biopharmaceutical sector to Indian companies on the behalf of Texcell.

The company would provide these services of Texcell in full compliance with Good Laboratory Practice and Good Manufacturing Practice standards in India, Arch said in a release.

"This representation of Texcell SA in India will enable us to provide long-term partnership to customers for providing testing facilities closer to their manufacturing entities in India," Arch Pharmalabs Chairman Ajit Kamath said in the release.

Arch would be the first company in the country to provide such services in India.

The company also plans a joint venture with the French firm in the country, the release said.